Pediatrix Medical Group Inc. (NYSE: MD) is -13.97% lower on its value in year-to-date trading and has touched a low of $17.17 and a high of $35.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MD stock was last observed hovering at around $23.64 in the last trading session, with the day’s loss setting it -0.23% off its average median price target of $22.00 for the next 12 months. It is also 21.97% off the consensus price target high of $30.00 offered by 11 analysts, but current levels are -46.31% lower than the price target low of $16.00 for the same period.
Currently trading at $23.41, the stock is 6.52% and 16.23% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.55 million and changing -0.97% at the moment leaves the stock -1.88% off its SMA200. MD registered -21.26% loss for a year compared to 6-month loss of -9.65%. The firm has a 50-day simple moving average (SMA 50) of $1.45 and a 200-day simple moving average (SMA200) of $14.00.
The stock witnessed a 22.69% gain in the last 1 month and extending the period to 3 months gives it a -1.39%, and is 3.45% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.22% over the week and 3.53% over the month.
Pediatrix Medical Group Inc. (MD) has around 2725 employees, a market worth around $2.01B and $1.95B in sales. Current P/E ratio is 24.54 and Fwd P/E is 11.18. Profit margin for the company is 4.70%. Distance from 52-week low is 36.34% and -34.38% from its 52-week high. The company has generated returns on investments over the last 12 months (8.50%).
Pediatrix Medical Group Inc. (MD) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Pediatrix Medical Group Inc. (MD) is a “Hold”. 11 analysts offering their recommendations for the stock have an average rating of 3.00, where 7 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Pediatrix Medical Group Inc. is expected to release its quarterly report on 11/03/2022.The EPS is expected to grow by 14.70% this year.
Pediatrix Medical Group Inc. (MD) Top Institutional Holders
The shares outstanding are 85.41M, and float is at 85.09M with Short Float at 5.78%.
Pediatrix Medical Group Inc. (MD) Insider Activity
A total of 19 insider transactions have happened at Pediatrix Medical Group Inc. (MD) in the last six months, with sales accounting for 6 and purchases happening 13 times. The most recent transaction is an insider sale by MEDEL ROGER MD,the company’sDirector. SEC filings show that MEDEL ROGER MD sold 40,107 shares of the company’s common stock on Jan 11 at a price of $26.58 per share for a total of $1.07 million. Following the sale, the insider now owns 0.74 million shares.
Pediatrix Medical Group Inc. disclosed in a document filed with the SEC on Jan 10 that MEDEL ROGER MD (Director) sold a total of 59,893 shares of the company’s common stock. The trade occurred on Jan 10 and was made at $26.44 per share for $1.58 million. Following the transaction, the insider now directly holds 0.78 million shares of the MD stock.
Still, SEC filings show that on Jan 05, MEDEL ROGER MD (Director) disposed off 12,639 shares at an average price of $27.42 for $0.35 million. The insider now directly holds 839,450 shares of Pediatrix Medical Group Inc. (MD).
Pediatrix Medical Group Inc. (MD): Who are the competitors?
The company’s main competitors (and peers) include Community Health Systems Inc. (CYH) that is trading -73.57% down over the past 12 months and Tenet Healthcare Corporation (THC) that is -16.99% lower over the same period. Universal Health Services Inc. (UHS) is -29.49% down on the 1-year trading charts.